Matching trials
1,853 results
- ESPAC-3An independent statistical analysis of ESPAC-3, a phase 3 randomized trial comparing chemotherapy regimens with observation in patients with completely resected pancreatic cancer.
- ESPRITComplete statistical analysis of ESPRIT, the randomized phase 3 trial of recombinant interleukin-2 in HIV-positive patients receiving antiretroviral therapy, including time-to-event, longitudinal CD4, categorical, safety, and statistical interpretation.
- ESTEEMIndependent statistical analysis of Combined Treatment for Mixed Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01959347).
- ETHOSA statistical and educational analysis of the ETHOS phase 3 randomized trial evaluating endoscopic full-thickness resection versus surgery for early colon cancer, including trial design, endpoints, planned analysis, and interpretation.
- EURAMOS-1Complete statistical analysis of EURAMOS-1, a randomized phase 3 trial of combination chemotherapy, peginterferon alfa-2b, and surgery in patients with localized or metastatic osteosarcoma.
- EUROMAXComplete statistical analysis of the EUROMAX phase 3 trial of bivalirudin versus standard-of-care heparins with optional GPI in acute coronary syndrome, including trial design, the primary binary endpoint, risk ratio, confidence interval,…
- EURTACIndependent statistical analysis of EURTAC, a randomized phase 3 trial comparing erlotinib with standard chemotherapy in advanced non-small cell lung cancer with EGFR TK-domain mutations, including progression-free survival, overall survival, trial design,…
- EVA-3SAn independent statistical analysis of EVA-3S, a phase 3 randomized trial concerning carotid angioplasty and stenting with cerebral protection in patients with severe symptomatic carotid stenosis.
- EVADEComplete statistical analysis of the randomized phase 2/3 EVADE trial of ADG20 for the prevention of COVID-19, including trial design, primary and secondary endpoints, risk differences, hazard ratios, statistical methodology, safety, and…
- Evaluate Safety of Tramadol in the Management of Postoperative Pain Following Surgery: Complete Statistical AnalysisIndependent statistical analysis of Evaluate Safety of Tramadol in the Management of Postoperative Pain Following Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression: primary endpoint results, effect estimate with confidence…
- Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen: Complete Statistical AnalysisIndependent statistical analysis of Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec: Complete Statistical AnalysisIndependent statistical analysis of Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection: primary endpoint results, effect…
- Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2): Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.: primary endpoint results, effect estimate with…
- Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women: primary endpoint results, effect estimate with confidence interval,…
- Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluation of a New Cardiac Biomarker Assay: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of a New Cardiac Biomarker Assay: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01608100).
- Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm PTCA Dilatation Catheter: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm PTCA Dilatation Catheter: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of Diagnostic HIV Ag/Ab Combo Assay: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Diagnostic HIV Ag/Ab Combo Assay: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00933933).
- Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Evaluation of Efficacy and Safety of Suzetrigine for Acute Pain After an Abdominoplasty: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Efficacy and Safety of Suzetrigine for Acute Pain After an Abdominoplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu: primary endpoint results, effect estimate with…
- Evaluation of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis (CF) Participants 12 to Less Than 24 Months of Age: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis (CF) Participants 12 to Less Than 24 Months of Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony): Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony): primary endpoint results, effect estimate with confidence interval, sample-size…
- Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluation of Preoperative N1539 in Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Preoperative N1539 in Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03434275).
- Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05011513).
- Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluation of the Efficacy and Safety of Indigo Naturalis Oil Extract on Psoriatic Nails: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Efficacy and Safety of Indigo Naturalis Oil Extract on Psoriatic Nails: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1): Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals’ HPV Vaccine in Healthy Indian Women: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058): Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation: primary endpoint results, effect estimate with confidence interval,…
- Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of Vitamin D Requirements During Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Vitamin D Requirements During Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00292591).
- EVARIndependent statistical analysis of Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04210180).
- EVarQuitIndependent statistical analysis of EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03262662).
- EVERESTIndependent statistical analysis of the phase 3 EVEREST trial of everolimus in combination with cyclosporine microemulsion in de novo renal transplant recipients, including trial design, endpoints, planned statistical methods, reported safety events,…
- EVITAIndependent statistical analysis of Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…